Search research articles
Contact Us
Filters
Showing results (71-80 of 95) with videos related to
Page
of 10
Sort By:
Thorax
|
December 6, 2019
MUC1 intracellular bioactivation mediates lung fibrosis
Javier Milara, Beatriz Ballester, Paula Montero, et al.
International Journal of Molecular Sciences
|
December 11, 2022
Increased Expression of Galectin-3 in Skin Fibrosis: Evidence from In Vitro and In Vivo Studies
Teresa Peiró, Miriam Alonso-Carpio, Pilar Ribera, et al.
Respiratory Research
|
November 10, 2016
Non-neuronal cholinergic system contributes to corticosteroid resistance in chronic obstructive pulmonary disease patients
Javier Milara, Angela Cervera, Alfredo de Diego, et al.
Thorax
|
June 7, 2013
Role of tetrahydrobiopterin in pulmonary vascular remodelling associated with pulmonary fibrosis
Patricia Almudéver, Javier Milara, Alfredo De Diego, et al.
European Journal of Pharmacology
|
June 11, 2013
Bafetinib inhibits functional responses of human eosinophils in vitro
Javier Milara, Maleles Martinez-Losa, Celia Sanz, et al.
Archivos De Bronconeumologia
|
June 17, 2011
A study of the effect of proinflammatory cytokines on the epithelial cells of smokers, with or without COPD
Alfredo De Diego Damiá, Julio Cortijo Gimeno, M José Selma Ferrer, et al.
Respiratory Research
|
November 22, 2018
MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease
Javier Milara, Lucía Díaz-Platas, Sonia Contreras, et al.
Cancers
|
March 10, 2022
Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients
Paula Montero, Martín Pérez-Leal, Jose Alejandro Pérez-Fidalgo, et al.
Journal of Comparative Effectiveness Research
|
September 4, 2019
Osimertinib in first-line treatment of advanced EGFR-mutated non-small-cell lung cancer: a cost-effectiveness analysis
Javier Aguilar-Serra, Vicente Gimeno-Ballester, Alfonso Pastor-Clerigues, et al.
Applied Health Economics and Health Policy
|
November 2, 2022
Determining What Represents Value in the Treatment of Refractory or Unexplained Chronic Cough from the Perspective of Key Stakeholders in Spain Using Multi-Criteria Decision Analysis
Christian Domingo, Mario Fernandez, Noe Garin, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 95) with videos related to
Sort By:
Page
of 10
Thorax
|
December 6, 2019
MUC1 intracellular bioactivation mediates lung fibrosis
Javier Milara, Beatriz Ballester, Paula Montero, et al.
International Journal of Molecular Sciences
|
December 11, 2022
Increased Expression of Galectin-3 in Skin Fibrosis: Evidence from In Vitro and In Vivo Studies
Teresa Peiró, Miriam Alonso-Carpio, Pilar Ribera, et al.
Respiratory Research
|
November 10, 2016
Non-neuronal cholinergic system contributes to corticosteroid resistance in chronic obstructive pulmonary disease patients
Javier Milara, Angela Cervera, Alfredo de Diego, et al.
Thorax
|
June 7, 2013
Role of tetrahydrobiopterin in pulmonary vascular remodelling associated with pulmonary fibrosis
Patricia Almudéver, Javier Milara, Alfredo De Diego, et al.
European Journal of Pharmacology
|
June 11, 2013
Bafetinib inhibits functional responses of human eosinophils in vitro
Javier Milara, Maleles Martinez-Losa, Celia Sanz, et al.
Archivos De Bronconeumologia
|
June 17, 2011
A study of the effect of proinflammatory cytokines on the epithelial cells of smokers, with or without COPD
Alfredo De Diego Damiá, Julio Cortijo Gimeno, M José Selma Ferrer, et al.
Respiratory Research
|
November 22, 2018
MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease
Javier Milara, Lucía Díaz-Platas, Sonia Contreras, et al.
Cancers
|
March 10, 2022
Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients
Paula Montero, Martín Pérez-Leal, Jose Alejandro Pérez-Fidalgo, et al.
Journal of Comparative Effectiveness Research
|
September 4, 2019
Osimertinib in first-line treatment of advanced EGFR-mutated non-small-cell lung cancer: a cost-effectiveness analysis
Javier Aguilar-Serra, Vicente Gimeno-Ballester, Alfonso Pastor-Clerigues, et al.
Applied Health Economics and Health Policy
|
November 2, 2022
Determining What Represents Value in the Treatment of Refractory or Unexplained Chronic Cough from the Perspective of Key Stakeholders in Spain Using Multi-Criteria Decision Analysis
Christian Domingo, Mario Fernandez, Noe Garin, et al.
Page
of 10